Tags

Type your tag names separated by a space and hit enter

Local steroid therapy in cutaneous hemangiomas.
Indian Pediatr 1996; 33(1):31-3IP

Abstract

OBJECTIVES

To evaluate the efficacy of intralesional triamcinolone in enhancing regression in various type of hemangiomas.

SETTING

Outpatients department of a teaching hospital Subjects: One hundred and five patients with rapidly growing surface hemangioma. The age ranged from 1 month to 15 months (mean 7 months).

INTERVENTION

Intralesional triamcinolone administered at monthly intervals, ranging from single injection to 7 injections (mean 3.6 injections).

MAIN OUTCOME MEASURE

Regression of the hemangioma.

RESULTS

The overall response rate was 88.6% (excellent 51.4%, and good 37.2%). Maximum response was observed in children below 1 year of age (> 90%), lesions over the face (92.8%) and strawberry hemangiomas (99.9%).

CONCLUSION

Intralesional administration of triamcinolone devoid of systemic side effects and an effective initial modality for rapidly growing hermangiomas.

Authors+Show Affiliations

Division of Pediatric Surgery and Plastic Surgery, Banaras Hindu University, Varanasi.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

8772948

Citation

Gangopadhyay, A N., et al. "Local Steroid Therapy in Cutaneous Hemangiomas." Indian Pediatrics, vol. 33, no. 1, 1996, pp. 31-3.
Gangopadhyay AN, Sharma SP, Gopal SC, et al. Local steroid therapy in cutaneous hemangiomas. Indian Pediatr. 1996;33(1):31-3.
Gangopadhyay, A. N., Sharma, S. P., Gopal, S. C., Gupta, D. K., Panjawani, K., & Sinha, J. K. (1996). Local steroid therapy in cutaneous hemangiomas. Indian Pediatrics, 33(1), pp. 31-3.
Gangopadhyay AN, et al. Local Steroid Therapy in Cutaneous Hemangiomas. Indian Pediatr. 1996;33(1):31-3. PubMed PMID: 8772948.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Local steroid therapy in cutaneous hemangiomas. AU - Gangopadhyay,A N, AU - Sharma,S P, AU - Gopal,S C, AU - Gupta,D K, AU - Panjawani,K, AU - Sinha,J K, PY - 1996/1/1/pubmed PY - 1996/1/1/medline PY - 1996/1/1/entrez SP - 31 EP - 3 JF - Indian pediatrics JO - Indian Pediatr VL - 33 IS - 1 N2 - OBJECTIVES: To evaluate the efficacy of intralesional triamcinolone in enhancing regression in various type of hemangiomas. SETTING: Outpatients department of a teaching hospital Subjects: One hundred and five patients with rapidly growing surface hemangioma. The age ranged from 1 month to 15 months (mean 7 months). INTERVENTION: Intralesional triamcinolone administered at monthly intervals, ranging from single injection to 7 injections (mean 3.6 injections). MAIN OUTCOME MEASURE: Regression of the hemangioma. RESULTS: The overall response rate was 88.6% (excellent 51.4%, and good 37.2%). Maximum response was observed in children below 1 year of age (> 90%), lesions over the face (92.8%) and strawberry hemangiomas (99.9%). CONCLUSION: Intralesional administration of triamcinolone devoid of systemic side effects and an effective initial modality for rapidly growing hermangiomas. SN - 0019-6061 UR - https://www.unboundmedicine.com/medline/citation/8772948/Local_steroid_therapy_in_cutaneous_hemangiomas_ L2 - https://medlineplus.gov/skincancer.html DB - PRIME DP - Unbound Medicine ER -